Details
| Originalsprache | Englisch |
|---|---|
| Seiten (von - bis) | e18-e20 |
| Fachzeitschrift | ASAIO Journal |
| Jahrgang | 70 |
| Ausgabenummer | 2 |
| Publikationsstatus | Veröffentlicht - 11 Juli 2023 |
Abstract
Blood pressure (BP) measurement is challenging among patients with continuous-flow left ventricular assist device (CF-LVAD) due to reduced pulse pressure (PP). Although Doppler opening BP (DOBP) is uniformly obtainable and provides an accurate measure of systolic BP (SBP), it routinely overestimates mean arterial pressure (MAP), particularly among CF-LVAD patients with higher PP. 1,2 The success rate of traditional cuff-based automated BP (ABP) monitors ranges from 50% to 80%, and is highly dependent on PP. 1–3 The HeartMate 3 (HM3, Abbott Labs) is the latest generation CF-LVAD with an improved pump design that resulted in significant reduction in mortality and hemocompatibility-related adverse events, 4 and, eventually, in a monopoly of the market. The HM3 features an artificial pulse which occurs asynchronously from the native.
ASJC Scopus Sachgebiete
- Chemische Verfahrenstechnik (insg.)
- Bioengineering
- Biochemie, Genetik und Molekularbiologie (insg.)
- Biophysik
- Ingenieurwesen (insg.)
- Biomedizintechnik
- Werkstoffwissenschaften (insg.)
- Biomaterialien
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: ASAIO Journal, Jahrgang 70, Nr. 2, 11.07.2023, S. e18-e20.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients
AU - Pinsino, Alberto
AU - Gaudig, Antonia
AU - Castagna, Francesco
AU - Mondellini, Giulio M
AU - McDonnell, Barry J
AU - Stöhr, Eric J
AU - Cockcroft, John
AU - Kormos, Robert L
AU - Sayer, Gabriel T
AU - Uriel, Nir
AU - Naka, Yoshifumi
AU - Takeda, Koji
AU - Yuzefpolskaya, Melana
AU - Colombo, Paolo C
N1 - Funding Information: Disclosure: R.L.K. is an employee of Abbott; N.U. received grant research support (Abbott and Medtronic) and is a medical advisory board member (Livemetric and Leviticus); P.C.C. received research grant support and consultant (Abbott). The other authors have no conflicts of interest to report. This work was supported from an Abbott Research Grant.
PY - 2023/7/11
Y1 - 2023/7/11
N2 - Blood pressure (BP) measurement is challenging among patients with continuous-flow left ventricular assist device (CF-LVAD) due to reduced pulse pressure (PP). Although Doppler opening BP (DOBP) is uniformly obtainable and provides an accurate measure of systolic BP (SBP), it routinely overestimates mean arterial pressure (MAP), particularly among CF-LVAD patients with higher PP. 1,2 The success rate of traditional cuff-based automated BP (ABP) monitors ranges from 50% to 80%, and is highly dependent on PP. 1–3 The HeartMate 3 (HM3, Abbott Labs) is the latest generation CF-LVAD with an improved pump design that resulted in significant reduction in mortality and hemocompatibility-related adverse events, 4 and, eventually, in a monopoly of the market. The HM3 features an artificial pulse which occurs asynchronously from the native.
AB - Blood pressure (BP) measurement is challenging among patients with continuous-flow left ventricular assist device (CF-LVAD) due to reduced pulse pressure (PP). Although Doppler opening BP (DOBP) is uniformly obtainable and provides an accurate measure of systolic BP (SBP), it routinely overestimates mean arterial pressure (MAP), particularly among CF-LVAD patients with higher PP. 1,2 The success rate of traditional cuff-based automated BP (ABP) monitors ranges from 50% to 80%, and is highly dependent on PP. 1–3 The HeartMate 3 (HM3, Abbott Labs) is the latest generation CF-LVAD with an improved pump design that resulted in significant reduction in mortality and hemocompatibility-related adverse events, 4 and, eventually, in a monopoly of the market. The HM3 features an artificial pulse which occurs asynchronously from the native.
KW - Doppler
KW - automated blood pressure monitor
KW - blood pressure
KW - left ventricular assist device
UR - http://www.scopus.com/inward/record.url?scp=85184345438&partnerID=8YFLogxK
U2 - 10.1097/MAT.0000000000002012
DO - 10.1097/MAT.0000000000002012
M3 - Article
C2 - 37429021
VL - 70
SP - e18-e20
JO - ASAIO Journal
JF - ASAIO Journal
SN - 0162-1432
IS - 2
ER -